French biotech stock soars 34% after new data on experimental medicine - CNBC
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
Search Group
Share To
Comments
About Screade
Screade® Inc. version 23b3692, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments